Curis | CRIS - Процентные расходы





Процентные расходы Изменить Дата
Alaunos Therapeutics USD 1.07M 215K 2023-06
Amgen USD 653M 94.99B 2026-09
AstraZeneca USD 371M 31M 2026-09
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 403M 4M 2026-09
CSL USD 215M 111M 2025-12
Curis USD 178K 441K 2023-12
Eli Lilly USD 316M 201.3M 2026-09
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Incyte USD 605K 23K 2026-09
Merck USD 525M 46M 2026-06
Novartis USD 468M 6M 2026-09
Pfizer USD 662M 5M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
Takeda JPY 63.38B 466M 2026-09
TG Therapeutics USD 16.57M 8.91M 2026-06
Verastem USD 382K 33K 2026-03